EyePoint Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(4)
WATERTOWN - EyePoint Pharmaceuticals, Inc. , a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced that...
Source: marketscreener.com